|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | Storage (From the date of receipt) |
3 years -20°C powder 1 years -80°C in solvent |
||||
| 化学式 | C20H25N5O3 |
||||||
| 分子量 | 383.44 | CAS No. | 1616391-65-1 | ||||
| Solubility (25°C)* | 体外 | DMSO (warmed with 50ºC water bath) | 76 mg/mL (198.2 mM) | ||||
| Ethanol (warmed with 50ºC water bath) | 39 mg/mL (101.71 mM) | ||||||
| Water | Insoluble | ||||||
| 体内 (毎回新しく調製した物を用意してください) |
|
||||||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||||||
| 製品説明 | EPZ015666 (GSK3235025) is a potent, selective and orally bioavailable PRMT5 inhibitor with Ki of 5 nM, >20,000-fold selectivity over other PMTs. |
|---|---|
| in vitro | EPZ015666 shows potent cellular activity that blocks symmetric dimethylation of SmD3 and inhibit proliferation of MCL cell lines (Z-138, Granta-519, Maver-1, Mino, and Jeko-1) with IC50 of 96-904 nM. [1] |
| in vivo | EPZ015666 (200 mg/kg, p.o.) displays robust anti-tumor activity in MCL xenograft animal models. [1] |
| 細胞アッセイ | 細胞株 | MCL cell lines (Z-138, Granta-519, Maver-1, Mino, and Jeko-1) |
|---|---|---|
| 濃度 | 5 μM | |
| 反応時間 | 12 days | |
| 実験の流れ | -- |
|
| 動物実験 | 動物モデル | MCL (Z-138, and Maver-1) xenograft models |
| 投薬量 | 200 mg/kg BID | |
| 投与方法 | p.o. |
|

Data from [Data independently produced by , , J Cell Mol Med, 2016, 1-10.]
| PRMT5 Promotes Pancreatic Cancer Tumorigenesis via Positive PRMT5/C-Myc Feedback Loop [ MedComm (2020), 2025, 6(6):e70150] | PubMed: 40384988 |
| Uncovering cell-type-specific immunomodulatory variants and molecular phenotypes in COVID-19 using structurally resolved protein networks [ Cell Rep, 2024, 43(11):114930] | PubMed: 39504244 |
| Arginine methylation of caspase-8 controls life/death decisions in extrinsic apoptotic networks [ Oncogene, 2024, 10.1038/s41388-024-03049-6] | PubMed: 38730267 |
| Genetic screen identified PRMT5 as a neuroprotection target against cerebral ischemia [ Elife, 2024, 12RP89754] | PubMed: 38372724 |
| Methylation of KSHV vCyclin by PRMT5 contributes to cell cycle progression and cell proliferation [ PLoS Pathog, 2024, 20(9):e1012535] | PubMed: 39255317 |
| Development and validation of a generic methyltransferase enzymatic assay based on an SAH riboswitch [ SLAS Discov, 2024, 29(4):100161] | PubMed: 38788976 |
| Genome-wide mapping of cancer dependency genes and genetic modifiers of chemotherapy in high-risk hepatoblastoma [ Nat Commun, 2023, 14(1):4003] | PubMed: 37414763 |
| FACS-based genome-wide CRISPR screens define key regulators of DNA damage signaling pathways [ Mol Cell, 2023, 83(15):2810-2828.e6] | PubMed: 37541219 |
| PRMT blockade induces defective DNA replication stress response and synergizes with PARP inhibition [ Cell Rep Med, 2023, 4(12):101326] | PubMed: 38118413 |
| Inhibition of histone methyltransferase PRMT5 attenuates cisplatin-induced hearing loss through the PI3K/Akt-mediated mitochondrial apoptotic pathway [ J Pharm Anal, 2023, 13(6):590-602] | PubMed: 37440906 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。